Why the Same Semaglutide Costs $69 or $1,299 a Month (What 370 Price Checks Show)

On 15 October 2026, a month of semaglutide cost $69 from one US telehealth program and $1,299 from another. Same molecule. Nineteen times the price.

Almost nobody publishes these numbers in one place, which is why we went looking for someone who does. PriceTracker GLP-1 reads 22 telehealth programs every week and has logged 370 dated price checks since August. This is what its data shows, how it gets the numbers, and where it stops being useful.

Why does the same GLP-1 cost five or nineteen times more depending on where you buy it?

Because "semaglutide" on a telehealth checkout page can mean three different products. It can be a compounded injection made by a pharmacy, a compounded tablet, or a brand pen (Wegovy or Ozempic) billed close to list price. All three are sold under the same word.

Then the pricing models pile on. Some programs charge one flat monthly price. Others quote a low drug price and add a membership fee. Others quote a monthly figure that only applies if you prepay six or twelve months. A headline of "$69 a month" can mean $69 billed monthly, or $828 paid on day one.

That is the problem a tracker solves. It turns every offer into one comparable number: what actually leaves your account each month, fees included.

If you have read our pieces on semaglutide and your genetics or how tirzepatide, retatrutide and semaglutide compare, you know the biology question: which drug fits you. The price question comes right after it, and it is just as messy.

What does a GLP-1 actually cost in October 2026?

PriceTracker's headline number is the GLP-1 Price Index: the median all-in monthly price across every program quoting a GLP-1 that day. Here is how it broke down on 15 October 2026.

Three things stand out once you read the table the way a buyer would.

1. The median has not moved in weeks

The index sat at $159 a month on both 14 September and 15 October 2026, a 30-day move of $0 across the same programs. The cheapest offer was $69 and had been flat since 20 August. If you are waiting for a price war, the data says it is not happening this autumn.

2. Tirzepatide carries a premium of roughly $18 at the middle

The tirzepatide median was $177 against $159 for semaglutide. At the cheap end the gap is $16 ($85 against $69). Over a year at the median, that is about $216 more for the dual-receptor drug. Whether it is worth it depends on how you respond, which is the question our GLP1R gene comparison tries to answer.

3. Brand pens live in a different price world

Lilly lists Zepbound at up to $1,086.37 a fill. That is the number insurance plans negotiate against, and it is why a compounded program at $85 looks so attractive. It is also why the comparison is not like for like, which we come back to below.

How does PriceTracker GLP-1 check a price?

This is the part that decides whether a price comparison is worth anything. Plenty of "best GLP-1" pages are sorted by who pays the highest commission. PriceTracker publishes its rules on its methodology page, and they are stricter than most.

Every price on this site is a dated observation of what a provider publicly advertised. Not an estimate, not a memory, and never a number anyone paid us to show.

PriceTracker GLP-1, methodology page, October 2026

In practice, a number has to clear four steps before it appears:

• Source. The price must appear on the seller's own public page. The tracker stores the URL and a verbatim quote of the sentence that states it.
• Date. Every observation carries the day it was read. The "checked" stamp on a card is that date.
• History. Observations are append-only. A price change adds a new dated point; the old one is never rewritten.
• Sanity gate. A price that moves more than 40% in one check is held for a human to review, because a scraping error looks exactly like a price drop.

The ranking rule is the one we would want as buyers: lists are ordered by price alone. The site does earn commission from some programs, labels those links as sponsored, and states that commission never changes the order. There is a separate score out of 10 (price 35%, flexibility 20%, patient reviews 20%, fees 15%, reach 10%), but it never reorders a list.

Can you check the numbers yourself?

Yes, and this is the feature that made us take the site seriously. PriceTracker publishes the full GLP-1 price dataset as CSV and JSON under a CC BY 4.0 licence: 119 prices across 22 programs in the 15 October version.

Each row has the program, the medication as the seller names it, the dose tier, the plan length, the advertised price, any separate membership fee, the all-in total, the date it was read, and the source URL. You can open any row, click through, and see whether the seller's page still says what the tracker says it said.

The same page counts federal records alongside the prices. Two that caught our eye: 56 of the 57 inspected 503B outsourcing facilities in FDA's table had been issued a Form 483, and FDA posted 79 GLP-1 warning letters between October 2025 and October 2026. Each figure links to the rows behind it.

How should you use a GLP-1 price tracker before you buy?

A ranking only helps if you read it with your own situation in mind. Here is the order we would go in.

Step 1: Check whether insurance changes the answer

Cash prices only matter if your plan will not pay. PriceTracker's insurance coverage checker quotes what each insurer and pharmacy benefit manager publishes about Wegovy, Zepbound and the rest, with the date it was read, and links prior authorization letter templates. It covered 18 plans and PBMs in October 2026.

Step 2: Price the whole first year, not the first month

Doses climb during titration, and some programs charge more per dose tier. The site's tirzepatide and semaglutide cost calculator multiplies prepaid terms and membership fees out over the months you will actually stay. A $69 headline on a 12-month plan is $828 on day one.

Step 3: Decide brand or compounded with your eyes open

The cheapest rows are compounded drugs. That is legal in specific circumstances, but it is not the same product as a brand pen. In FDA's own words, the agency "does not review compounded drugs for safety, effectiveness or quality before they are marketed" (FDA). PriceTracker labels which is which on every row.

Step 4: Start month to month

This is where genetics and price meet. If you do not yet know how you respond to semaglutide or tirzepatide, a long prepay is a bet on an unknown. The tracker's cheapest-first ranking lets you filter by plan length, so you can see the month-to-month price next to the prepaid one.

If you turn out to be one of the 10 to 17% who barely respond, that difference is the money you keep. Our piece on semaglutide non-responders covers the gene behind that gap.

Where does PriceTracker GLP-1 fall short?

No tool is right for everyone, and this one has clear edges.

• It is US only. Every program it tracks is a US telehealth service. If you are in the EU or UK, none of them can ship to you, and the prices say nothing about your market.
• It covers cash telehealth, not your local pharmacy. Retail pharmacy prices with a discount card, and manufacturer direct programs, appear as context rather than on the main board.
• It lists partner programs. The site says plainly that it lists and links only programs it partners with. Paused programs keep their pages but are marked as not partnered. A program it has no deal with can still be cheaper somewhere else.
• It is not medical advice. The founder is not a clinician. The site tracks what things cost; whether a GLP-1 is right for you is a conversation with your prescriber.
• Prices are a week old at worst. Weekly checks are fast for this market, but a seller can change a price the day after a check. The date stamp tells you how old each number is.

None of these are hidden. The about page names who runs the site and how it makes money, which is more than most GLP-1 comparison sites manage.

What else is on the site?

Beyond the board and the index, PriceTracker GLP-1 has eight free calculators (dosing in syringe units, titration cost, BMI against the label criteria, a Medicare GLP-1 Bridge checker, a weight-loss projection based on trial averages), a page for every US state showing which programs ship there, and a library of 1,585 vetted videos on Ozempic, Zepbound, Wegovy and the compounded versions. Its sources page lists 532 primary sources behind its prices and facts.